Technical advances in ostomy drainage bags are expected to drive the future growth in the market. Continent ileostomy and urostomy are surgical procedures that use part of ileum to create an internal reservoir for the collection of feces and urine. This procedure eliminates the need for external bags. The procedure configures the portion of ileum that serves as a valve in an isoperistaltic positioning, in turn increasing its stability by moving the peristalsis towards the pouch. The Transcutaneous Implant Evacuation System (TIES), a registered trademark by Ostomycure AS, is a technology that avoids the shortcomings of conventional ostomy bags.
The primary application of TIES is for patients who have their colon or urinary bladder removed. The system consists of a titanium port that can be implanted in the stomach, allowing the ileum to grow to the port. The opening of the port is covered by a lid that means the patient no longer needs to wear a stoma pouch. This eliminates the psychosocial problems, unwanted noise, leakages, smells, skin problems, and requirements for nursing that are associated with stoma pouches. The technology also has the potential to provide significant cost savings compared to conventional ostomy drainage bags. These advances have also led to significant progress in urinary and fecal diversions in addition to reductions in morbidity associated with radical pelvic surgery and other major surgical procedures.
GBI Research's report "Ostomy Drainage Bags Market to 2019 - Technical Advances Increase Patient Convenience but Unfavorable Reimbursement Scenarios Limit Growth Potential" provides a synopsis of the various factors influencing this market. The report also gives company descriptions and lists the key marketed products for major market players.